Open
The Marked Chart Wire · Business
Novartis
Novartis booked $2.2 billion in charges for failed drugs, causing reported operating income to drop 61 percent. Core income rose 10 percent, prompting the company to lift its full-year profit forecast.
Part of a series: Novartis lifts profit outlook after drug trial success
Prices from Live · updated 9:55 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Novartis
The pharmaceutical company raised its expected growth in core earnings to a range of in line to low single digits, keeping its net sales projection unchanged.
AI Debt
H.I.G. Capital included a provision in a $524 million loan for Terras Group that suspends default consequences if AI harms the business. Lenders rejected similar language in Bain Capital's $5.3 billion financing for Everllence.
Deals
The firms will integrate Ripple's RLUSD stablecoin and treasury tools across Robinhood's platforms, including Bitstamp. RLUSD is already live on Robinhood Chain, with app availability expected later in 2026.
BlueChip
The rugged device features Snapdragon X processors made in Arizona and aims for 100 percent domestic sourcing. Preorders are set for 2027, with prices expected to be 20 percent higher than standard premium models.
HotMeta
The company priced its new Class A stock issuance at $625 per share, raising $25 billion in total.
HotDeals
Nvidia pledged $3 billion to Meta Platforms, which intends to secure $95 billion for AI data centers. The two firms will also expand cooperation on new processors and AI agents.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.